{"id":19829,"date":"2024-02-19T20:10:35","date_gmt":"2024-02-20T01:10:35","guid":{"rendered":"https:\/\/arsacs.com\/?p=19829"},"modified":"2026-03-16T18:15:55","modified_gmt":"2026-03-16T22:15:55","slug":"dr-marc-riviere-joins-the-foundations-board","status":"publish","type":"post","link":"https:\/\/2026.arsacs.com\/fr\/dr-marc-riviere-joins-the-foundations-board\/","title":{"rendered":"Dr. Marc Rivi\u00e8re joins the Foundation&#8217;s Board"},"content":{"rendered":"<p>The Ataxie Charlevoix-Saguenay Foundation is very pleased to announce that Dr. Marc Rivi\u00e8re has joined its board of directors. An  executive with extensive experience creating and managing clinical programs, Dr. Rivi\u00e8re\u2019s expertise encompasses all aspects of drug development.<\/p>\n\n\n\n<p> His experience in clinical trials and his knowledge of the pharmaceutical industry could make a significant contribution to the advancement of work on ARSACS. Dr. Rivi\u00e8re is a General Partner and Chief Medical Officer at TVM Life Science Management.<\/p>\n\n\n\n<p><\/p>","protected":false},"excerpt":{"rendered":"<p>The Ataxie Charlevoix-Saguenay Foundation is very pleased to announce that Dr. Marc Rivi\u00e8re has joined its board of directors. An executive with extensive experience creating and managing clinical programs, Dr. Rivi\u00e8re\u2019s expertise encompasses all aspects of drug development. His experience in clinical trials and his knowledge of the pharmaceutical industry could make a significant contribution [&#8230;]<\/p>\n","protected":false},"author":3,"featured_media":19809,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[],"class_list":["post-19829","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/2026.arsacs.com\/fr\/wp-json\/wp\/v2\/posts\/19829","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/2026.arsacs.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/2026.arsacs.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/2026.arsacs.com\/fr\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/2026.arsacs.com\/fr\/wp-json\/wp\/v2\/comments?post=19829"}],"version-history":[{"count":6,"href":"https:\/\/2026.arsacs.com\/fr\/wp-json\/wp\/v2\/posts\/19829\/revisions"}],"predecessor-version":[{"id":24950,"href":"https:\/\/2026.arsacs.com\/fr\/wp-json\/wp\/v2\/posts\/19829\/revisions\/24950"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/2026.arsacs.com\/fr\/wp-json\/wp\/v2\/media\/19809"}],"wp:attachment":[{"href":"https:\/\/2026.arsacs.com\/fr\/wp-json\/wp\/v2\/media?parent=19829"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/2026.arsacs.com\/fr\/wp-json\/wp\/v2\/categories?post=19829"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/2026.arsacs.com\/fr\/wp-json\/wp\/v2\/tags?post=19829"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}